| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/12/2001 | EP0687300B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/12/2001 | EP0666751B1 Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines |
| 09/12/2001 | EP0637249B1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 09/12/2001 | EP0621898B1 Chimeric immunogens |
| 09/12/2001 | EP0449856B1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 09/12/2001 | CN1312725A Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1070697C Method of preparing novel microcapsule |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |
| 09/11/2001 | US6288214 Antibody which binds to preferential peptide and prevents bacterial infection |
| 09/11/2001 | US6288035 Administering polypeptide as antitumor agent to treat melanoma; medical diagnosis |
| 09/11/2001 | US6287866 β-casein expressing constructs |
| 09/11/2001 | US6287861 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 09/11/2001 | US6287856 Beak and feather disease nucleic acids; genetically engineered proteins made from open reading frame vectors; veterinary medicine |
| 09/11/2001 | US6287853 Genetically engineered escherichia plasmid; marking antibiotic resistance; artificial chromosomes; genetic mapping |
| 09/11/2001 | US6287836 Histidine kinase from Streptococcus pneumoniae and compositions therecontaining |
| 09/11/2001 | US6287815 Spodoptera frugiperda cells produce vp1 capsid protein using a baculovirus expression system |
| 09/11/2001 | US6287804 nrdG |
| 09/11/2001 | US6287803 Polynucleotides encoding a novel era polypeptide |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287761 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 09/11/2001 | US6287759 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/11/2001 | US6287604 Biodegradable targetable microparticle delivery system |
| 09/11/2001 | US6287575 Vaccine against papillomatous digital dermatitis (PDD) |
| 09/11/2001 | US6287574 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/11/2001 | US6287573 Injectable vaccine |
| 09/11/2001 | US6287572 Genetic engineering |
| 09/11/2001 | US6287571 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 09/11/2001 | US6287570 Purified dna |
| 09/11/2001 | US6287569 Vaccines with enhanced intracellular processing |
| 09/11/2001 | US6287566 Isolated polypeptide |
| 09/11/2001 | US6287565 Modified HGP-30 heteroconjugates, compositions and methods of use |
| 09/11/2001 | US6287563 Administering heat labile entertoxin |
| 09/11/2001 | US6287561 Pathogen-targeted biocatalysts |
| 09/11/2001 | US6287556 Intracellular delivery vehicles |
| 09/11/2001 | US6287555 Method and vaccine for prevention of over-production of acid in the rumen or gut of animals |
| 09/11/2001 | US6287554 Chicken interleukin-15 and uses thereof |
| 09/11/2001 | CA1341291C Vaccines based on membrane bound proteins and process for making them |
| 09/07/2001 | WO2001064949A2 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | WO2001064944A1 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 09/07/2001 | WO2001064886A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064877A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064874A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 09/07/2001 | WO2001064872A2 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 09/07/2001 | WO2001064869A2 Tumor-related antigen |
| 09/07/2001 | WO2001064860A2 Recombinant influenza a viruses |
| 09/07/2001 | WO2001064856A2 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 09/07/2001 | WO2001064846A1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| 09/07/2001 | WO2001064752A2 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 09/07/2001 | WO2001064751A2 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064749A2 Method for preparing anti-mif antibodies |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064737A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/07/2001 | WO2001064712A1 Methods for detection and treatment of neural cancers |
| 09/07/2001 | WO2001064704A1 hB7-H2, A NOVEL CO-STIMULATORY MOLECULE |
| 09/07/2001 | WO2001064252A2 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
| 09/07/2001 | WO2001064249A1 Tissue decomposition inhibitor |
| 09/07/2001 | WO2001064248A1 Methods of enhancing activity of vaccines and vaccine compositions |
| 09/07/2001 | WO2001064247A2 Method of treating cancer with anti-neurotrophin agents |
| 09/07/2001 | WO2001064246A2 Farnesyl protein transferase inhibitor combinations with an her2 antibody |
| 09/07/2001 | WO2001064245A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | WO2001064244A2 In ovo protection against infectious bronchitis |
| 09/07/2001 | WO2001064243A2 Use of toxoplasma gondii mic3 protein as immunogenic agent |
| 09/07/2001 | WO2001064235A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d |
| 09/07/2001 | WO2001064186A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | WO2001064031A2 Slpi knockout mice and methods for wound treatment |
| 09/07/2001 | WO2001064008A2 Vaccine for the treatment of artherosclerosis |
| 09/07/2001 | WO2001016294A3 Metal binding compounds and their use in cell culture medium compositions |
| 09/07/2001 | WO2001016163A3 Peptide mixture and vaccine against a chronic viral infection |
| 09/07/2001 | WO2001015727A3 Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof |
| 09/07/2001 | WO2001014395A3 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 09/07/2001 | WO2001012812A3 Baff receptor (bcma), an immunoregulatory agent |
| 09/07/2001 | WO2001010469A3 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000076528A3 Pharmaceutical preparation containing proteins |
| 09/07/2001 | WO2000050580B1 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 09/07/2001 | WO2000047227A9 Mycobacterium tuberculosis, immunization |
| 09/07/2001 | CA2402054A1 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 09/07/2001 | CA2401804A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | CA2401775A1 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | CA2401755A1 Vaccine for the treatment of artherosclerosis |
| 09/07/2001 | CA2401665A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d |
| 09/07/2001 | CA2401652A1 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | CA2401633A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase .beta./.zeta. |
| 09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2401357A1 Tissue degradation inhibitor agent |
| 09/07/2001 | CA2401352A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2401145A1 In ovo protection against infectious bronchitis |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/07/2001 | CA2400376A1 Methods for detection and treatment of neural cancers |
| 09/07/2001 | CA2397448A1 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
| 09/07/2001 | CA2397349A1 Farnesyl protein transferase inhibitor combinations with an her2 antibody |
| 09/06/2001 | US20010020010 Polypeptide |